Triska J, Tamargo J, Bozkurt B, Elkayam U, Taylor A, Birnbaum Y
Cardiovasc Drugs Ther. 2022; 37(6):1205-1223.
PMID: 35357604
DOI: 10.1007/s10557-022-07334-y.
Stams T, Bourgonje V, Vos M, van der Heyden M
Br J Pharmacol. 2011; 166(2):554-6.
PMID: 22188337
PMC: 3417487.
DOI: 10.1111/j.1476-5381.2011.01818.x.
Murphy C, Dargie H
Drug Saf. 2007; 30(9):783-804.
PMID: 17722970
DOI: 10.2165/00002018-200730090-00005.
Little W, Cheng C, Elvelin L, NORDLANDER M
Cardiovasc Drugs Ther. 1995; 9(5):657-63.
PMID: 8573548
DOI: 10.1007/BF00878548.
Su J, Renaud N, Carayon A, Crozatier B, Hittinger L
Br J Pharmacol. 1994; 113(2):395-402.
PMID: 7834190
PMC: 1510131.
DOI: 10.1111/j.1476-5381.1994.tb17002.x.
Detrimental effects of verapamil in patients with primary pulmonary hypertension.
Packer M, Medina N, Yushak M, WIENER I
Br Heart J. 1984; 52(1):106-11.
PMID: 6743418
PMC: 481593.
DOI: 10.1136/hrt.52.1.106.
Clinical pharmacokinetics of verapamil.
Hamann S, Blouin R, McAllister Jr R
Clin Pharmacokinet. 1984; 9(1):26-41.
PMID: 6362951
DOI: 10.2165/00003088-198409010-00002.
Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol.
Rowland E, Razis P, Sugrue D, Krikler D
Br Heart J. 1983; 50(4):383-9.
PMID: 6354228
PMC: 481427.
DOI: 10.1136/hrt.50.4.383.
Cardiac rhythm in hypertension assessed through 24 hour ambulatory electrocardiographic monitoring. Effects of load manipulation with atenolol, verapamil, and nifedipine.
Loaldi A, Pepi M, Agostoni P, Fiorentini C, GRAZI S, Della Bella P
Br Heart J. 1983; 50(2):118-26.
PMID: 6224499
PMC: 481383.
DOI: 10.1136/hrt.50.2.118.
Are calcium antagonists cardioprotective?.
Kendall M, Horton R
J R Coll Physicians Lond. 1985; 19(2):85-9.
PMID: 3889321
PMC: 5371016.
[Calcium antagonists in heart failure?].
Drexler H, Just H
Klin Wochenschr. 1986; 64(20):993-1002.
PMID: 3784463
DOI: 10.1007/BF01757206.
Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery disease.
Silke B, Graham D, Verma S, Reynolds G, Frais M, Finlayson J
Eur J Clin Pharmacol. 1986; 29(6):651-7.
PMID: 3709609
DOI: 10.1007/BF00615954.
Calcium antagonists and chronic cardiac failure.
Kendall M, Horton R, Smith S
Postgrad Med J. 1986; 62(730):713-7.
PMID: 3534840
PMC: 2418843.
DOI: 10.1136/pgmj.62.730.713.
Vasodilator therapy in the perioperative period.
Fyman P, Cottrell J, Kushins L, Casthely P
Can Anaesth Soc J. 1986; 33(5):629-43.
PMID: 3533238
DOI: 10.1007/BF03014269.
The Danish studies on verapamil in acute myocardial infarction. The Danish Study Group on Verapamil in Myocardial Infarction.
Br J Clin Pharmacol. 1986; 21 Suppl 2:197S-204S.
PMID: 3530301
PMC: 1400727.
Haemodynamic effects of verapamil administration after large doses of fentanyl in man.
Kapur P, Norel E, Dajee H, Cohen G, Flacke W
Can Anaesth Soc J. 1986; 33(2):138-44.
PMID: 3486029
DOI: 10.1007/BF03010822.
Effects of intravenous verapamil on left ventricular systolic function and diastolic filling dynamics in patients with coronary artery disease: analysis of intramyocardial markers.
Amende I, Simon R, Seegers A, Hood Jr W, Schmittenkoetter H
Int J Card Imaging. 1988; 3(2-3):169-76.
PMID: 3262699
DOI: 10.1007/BF01814890.
Calcium antagonists--adverse drug interactions.
Reicher-Reiss H, NEUFELD H, Ebner F
Cardiovasc Drugs Ther. 1987; 1(4):403-9.
PMID: 2908714
DOI: 10.1007/BF02209082.
The medical treatment of angina pectoris.
Chamberlain D
Br Heart J. 1987; 58(6):547-51.
PMID: 2892516
PMC: 1277332.
DOI: 10.1136/hrt.58.6.547.
The haemodynamic effects of nifedipine, verapamil and diltiazem in patients with coronary artery disease. A review.
Soward A, Vanhaleweyk G, Serruys P
Drugs. 1986; 32(1):66-101.
PMID: 2874975
DOI: 10.2165/00003495-198632010-00004.
